Caitong International Asset Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Hold
1
﹤0.01% 2499
2025
Q4
$2 Sell
1
-238
-100% -$380 ﹤0.01% 1824
2025
Q3
$378 Sell
239
-1,304
-85% -$2.27K ﹤0.01% 1589
2025
Q2
$3.36K Buy
+1,543
New +$3.74K ﹤0.01% 1187
2025
Q1
Sell
-163
Closed -$678 2409
2024
Q4
$678 Buy
+163
New +$616 ﹤0.01% 1405

Other funds holding MXCT

Caitong International Asset Management's MXCT Position: Q1 2026 in Review

Caitong International Asset Management held its MaxCyte (MXCT) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Caitong International Asset Management first reported a position in MXCT in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.36K in Q2 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Caitong International Asset Management held 1 share of MaxCyte worth $1 as of Q1 2026.
  • Caitong International Asset Management left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2499 holding.
  • Caitong International Asset Management first reported a position in MaxCyte in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's MaxCyte position peaked at $3.36K in Q2 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.